Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Abbott Laboratories

ABT ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Large Cap Analyst: BUY

Last Close

$111.25

▼ -0.02%

Market Cap $192.51B · Vol 1.86M

Key Metrics

P/E Ratio

35.81

FWD: 19.01

Market Cap

$192.51B

Large Cap

Div Yield

2.26%

Quarterly dividend

EPS Growth

+7.13%

YoY

RSI (14)

72.24

Momentum

Beta

0.59

vs Market

52W High

$137.45

19.06% below

52W Low

$81.98

35.70% above

Volume

1.86M

Avg 2.84M

P/B

4.17

Price-to-book

ROE

18.12%

Return on equity

Free Float

99.48%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Abbott Laboratories (ABT) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ABT pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.19%

+25.06%

+31.04%

-1.27%

YTD

-11.21%

-13.95%

+6.01%

-9.60%

Financials & Valuation

TTM · Annual

Total Revenue	$44.33B
Net Income	$6.52B
Revenue Growth (YoY)	+13.02%
Gross Margin	52.87%
Operating Margin	18.85%
Net Profit Margin	14.72%
ROE	18.12%
ROA · ROIC	10.07% · 10.81%

P/E Ratio	35.81
Forward P/E (FY1)	19.01
PEG Ratio	-0.65
P/S	4.94
P/B	4.17
P/FCF	29.62
EPS Growth	+7.13%
Outstanding Shares	1.73B

Technical Indicators

50-Day SMA	$97.63
200-Day SMA	$107.36
RSI (14)	72.24
Beta	0.59
52-Week High	$137.45
52-Week Low	$81.98

Volume Today	1.86M
Avg Daily Volume (30D)	2.84M
Relative Volume	0.66x
Volatility (10D)	14.96
Volatility (30D)	35.74
Free Float	99.48%

Analyst Consensus

BUY

Current Price $111.25

Mean Target $120.92

52W Low$81.98 52W High$137.45

Current

Target

$81.98 $137.45

Current Analyst target

+8.69% upside potential · 30 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S5N9M6

ISINUS0028241000

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateOct 13, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79% MDLN Medline Inc +0.45%

Company Profile

Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.